National Comprehensive Cancer Network

Home
United States
Plymouth Meeting, PA
National Comprehensive Cancer Network

National Comprehensive Cancer Network is a not-for-profit alliance of 33 leading cancer centers. NCCN Foundation® is the philanthropic arm of NCCN.

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of leading cancer centers is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve and facilitate quality, effective, equitable, and accessible cancer care so all patients can live better lives. NCCN Foundation relies solely on donations and support from the community to fund the development and distribution of NCCN Guidelines for Patients® and the Young Investigator Awards (YIA) Program for promising young cancer researchers. We appreciate your generous support! Donate Now: NCCNfoundation.org/donate

The NCCN Member Institutions are:
Abramson Cancer Center at the University of Pennsylvania
Fred & Pamela Buffett Cancer Center
Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
City of Hope Comprehensive Cancer Center
Dana-Farber/Brigham and Women's Cancer Center |
Massachusetts General Hospital Cancer Center
Duke Cancer Institute
Fox Chase Cancer Center
Huntsman Cancer Institute at the University of Utah
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Fred Hutchinson Cancer Center
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Mayo Clinic Comphrensive Cancer Center
Memorial Sloan Kettering Cancer Center
Moffitt Cancer Center
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
O'Neal Comprehensive Cancer Center at UAB
Roswell Park Cancer Institute
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
Stanford Cancer Institute
UC Davis Comprehensive Cancer Center
UC San Diego Moores Cancer Center
UCLA Jonsson Comprehensive
Cancer Center
UCSF Helen Diller Family Comprehensive Cancer Center
University of Colorado Cancer Center
University of Michigan Comprehensive Cancer Center
The University of Texas MD Anderson Cancer Center
University of Wisconsin Carbone Cancer Center
UT Southwestern Simmons Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Yale Cancer Center/Smilow Cancer Hospital

10/25/2025

We are at ! Visit NCCN at booth #813 to learn more about NCCN programs and pick up FREE pocket-sized guidelines, patient guidelines, and more!

10/24/2025

NCCN is at ! Stop by booth #813 to learn about NCCN Guidelines in Practice™, discover upcoming events, pick up FREE patient guidelines, and more!

10/23/2025

Registration for the NCCN 2026: Breast Cancer Congress with Updates from the 2025 San Antonio Breast Cancer Symposium. Educational sessions will highlight treatment advances and supportive care options in breast cancer.
Register now: https://www.nccn.org/breast-congress

10/22/2025

We are excited to invite you to the 2026 Annual Conference! This year’s agenda offers curated sessions focusing on the practical management of patients living with or at risk for cancer and best practices for cancer care delivery.
Be one of the first to register today and enjoy discounts: NCCN.org/conference

10/20/2025

Join us virtually on December 5 for a webinar focusing on aligning discovery with clinical practice: applying expert consensus guidelines to improve patient outcomes in CLL/SLL. Register now to attend and earn CE credit: https://clinicaloptions.com/events/nccn-cllsll/nccn-cllsll/21665-35870

10/17/2025

Did you register for the NCCN 2025 Lung Cancer Congress? Share this message with your colleagues to encourage them to join you!
Learn more: https://www.nccn.org/education-research/educational-events-and-programs/share-that-you-are-attending-an-nccn-event

10/15/2025

The Call for Abstracts for the General Poster Session is closing soon! NCCN welcomes original abstracts from all investigators in the general oncology community. The submission deadline is Wednesday, October 29, 2025, 11:59 PM ET.
Learn more and submit now: https://www.nccn.org/conference

10/14/2025

People facing a cancer diagnosis deserve the best information to guide their care choices. With your help, NCCN Foundation raises funds to make free, expert information accessible to people diagnosed with cancer. Donations can be made here: https://nccnfoundation.givingfuel.com/2025-fall-appeal

10/13/2025

October is ! Access the recorded presentation CDK4/6 Inhibition in Breast Cancer: Expert Perspectives on Integrating Guideline Updates and Recent Advances Into Practice. The goal of this activity is to improve learners’ knowledge, competence, and confidence to integrate CDK4/6 inhibitors into practice to improve clinical outcomes in patients with early and metastatic breast cancer.
Learn more: https://education.nccn.org/breast-cancer

10/11/2025

Thank you to everyone who attended and participated in the NCCN 2025 Annual Congress: Hematologic Malignancies! Attendees can access sessions virtually for up to 60 days. Be sure to save the dates for the NCCN 2026 Hematologic Malignancies congress happening September 18-19, 2026 in New York City. View more upcoming events at https://www.nccn.org/events. .

$The final sessions of the Hematologic Malignancies Congress will explore evolving treatment options for relapsed/refract...$

10/11/2025

The final sessions of the Hematologic Malignancies Congress will explore evolving treatment options for relapsed/refractory follicular lymphoma, first-line therapy for diffuse large B-cell lymphoma, and novel treatment options for Hodgkin lymphoma. https://bit.ly/Hem2025

10/11/2025

Welcome to the second and final day of the NCCN 2025 Annual Congress: Hematologic Malignancies™! Morning sessions will begin with topics focusing on the role of minimal residual disease in hematologic malignancies, evolving treatment options for relapsed/refractory follicular lymphoma, and more.
You can still register to attend virtually: https://bit.ly/Hem2025

Address

3025 Chemical Road, Suite 100
Plymouth Meeting, PA
19462

Website

http://www.nccn.org/

Alerts

Be the first to know and let us send you an email when National Comprehensive Cancer Network posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to National Comprehensive Cancer Network:

Shortcuts

Want your practice to be the top-listed Clinic in Plymouth Meeting?

10/25/2025

10/24/2025

10/23/2025

10/22/2025

10/20/2025

10/17/2025

10/15/2025

10/14/2025

10/13/2025

10/11/2025

10/11/2025

10/11/2025

Address

Website

Alerts

Contact The Practice

Shortcuts

Share

Category